Tyawalt 450 mg/g granules for use in drinking water for pigs
Tyawalt 450 mg/g granules for use in drinking water for pigs
Authorised
- Tiamulin hydrogen fumarate
Product identification
Medicine name:
Tyawalt 450 mg/g granules for use in drinking water for pigs
TYAWALT 364,28 MG/G GRANULES POUR ADMINISTRATION DANS L'EAU DE BOISSON DES PORCS, DES POULETS ET DES DINDES
Active substance:
- Tiamulin hydrogen fumarate
Target species:
-
Pig
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Tiamulin hydrogen fumarate450.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Granules for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Pig
-
Meat and offal2day(8.8 mg tiamulin hydrogen fumarate (equivalent to 19.6 mg of product)/kg body weight).
-
Meat and offal4day(20 mg tiamulin hydrogen fumarate (equivalent to 44.4 mg of product)/kg body weight).
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XQ01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- (ID2) 5 kilogram(s): unspecified outer container with 1 Bag (Low Density PolyEthylene; Aluminium; PolyEthylene TerePhthalate) with 5 kilogram(s)
- (ID1) 1 kilogram(s): unspecified outer container with 1 Bag (Low Density PolyEthylene; Aluminium; PolyEthylene TerePhthalate) with 1 kilogram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
- TAD Pharma GmbH
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/8453675 4/2017
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0264/001
Concerned member states:
-
Belgium
-
Denmark
-
France
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 27/09/2023
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 15/10/2025